SCHEMBL5501650

SCHEMBL5501650

OC(O)(O)NC1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
HSD17B10 Q99714 1/20 0.45
EPHX1 P07099 5/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
CYP3A4 P08684 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 2/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
EPHX2 P34913 1/20 0.42
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38
SIGMAR1 Q99720 3/20 0.37
ADH1B P00325 1/20 0.36
ADH1C P00326 1/20 0.36
ADH1A P07327 1/20 0.36
ADH4 P08319 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16765831 0.97 ALDH1A1 (0.40) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4
SCHEMBL3393818 0.78 PDK1 (0.48) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4
SCHEMBL183427 0.78 PDK1 (0.44) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4
SCHEMBL1153020 0.78 PDK1 (0.44) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4
SCHEMBL28292813 0.74 PDK1 (0.41) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4
SCHEMBL1725786 0.73 ALDH1A1 (0.47) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4
SCHEMBL19144522 0.72 EPHX1 (0.36) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4
SCHEMBL12570881 0.71 MMP2 (0.45) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4
SCHEMBL7778173 0.71 ALDH1A1 (0.45) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4
SCHEMBL50080 0.71 ALDH1A1 (0.45) ALDH1A1HSD17B10EPHX1SMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276484-B2 Dipeptide inhibitors of β-secretase ELAN PHARMACEUTICALS, INC. (US) 2007-10-02 US disclosed
US-20050182138-A1 Dipeptide inhibitors of beta-secretase ELAN PHARMACEUTICALS, INC. 2005-08-18 US disclosed
US-6864240-B1 Dipeptide inhibitors of β-secretase ELAN PHARMACEUTICALS, INC. (US) 2005-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182138-A1 Dipeptide inhibitors of beta-secretase BACE1, APP, BACE2 ALDH1A1 3256/4885HSD17B10 2493/4885EPHX1 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.